275 related articles for article (PubMed ID: 23806227)
21. Solution-combustion synthesis of doped TiO
Lopera AA; Velásquez AMA; Clementino LC; Robledo S; Montoya A; de Freitas LM; Bezzon VDN; Fontana CR; Garcia C; Graminha MAS
J Photochem Photobiol B; 2018 Jun; 183():64-74. PubMed ID: 29689488
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological evaluation of anti-leishmanial activity by in vivo nitric oxide modulation in Balb/c mice infected with Leishmania major MRHO/IR/75/ER: an Iranian strain of cutaneous leishmaniasis.
Nahrevanian H; Farahmand M; Aghighi Z; Assmar M; Amirkhani A
Exp Parasitol; 2007 Jul; 116(3):233-40. PubMed ID: 17335813
[TBL] [Abstract][Full Text] [Related]
23. Comparison of biosynthetic zinc oxide nanoparticle and glucantime cytotoxic effects on Leishmania major (MRHO/IR/75/ER).
Saleh F; Kheirandish F; Abbasi M; Ahmadpour F; Veiskarami S; Mirderikvand A
J Basic Microbiol; 2024 May; 64(5):e2300490. PubMed ID: 38227394
[TBL] [Abstract][Full Text] [Related]
24. Chitosan-titanium dioxide-glucantime nanoassemblies effects on promastigote and amastigote of Leishmania major.
Varshosaz J; Arbabi B; Pestehchian N; Saberi S; Delavari M
Int J Biol Macromol; 2018 Feb; 107(Pt A):212-221. PubMed ID: 28867228
[TBL] [Abstract][Full Text] [Related]
25. Amphotericin B-loaded nanoparticles for local treatment of cutaneous leishmaniasis.
Abu Ammar A; Nasereddin A; Ereqat S; Dan-Goor M; Jaffe CL; Zussman E; Abdeen Z
Drug Deliv Transl Res; 2019 Feb; 9(1):76-84. PubMed ID: 30484256
[TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo anti-parasitic activity of biogenic antimony sulfide nanoparticles on Leishmania major (MRHO/IR/75/ER).
Mohtasebi S; Mohebali M; Elikaee S; Akhoundi B; Foroushani AR; Teimouri A; Yarizadeh H
Parasitol Res; 2019 Sep; 118(9):2669-2678. PubMed ID: 31278518
[TBL] [Abstract][Full Text] [Related]
27. Visible light-induced antibacterial activity of metaloxide nanoparticles.
Lipovsky A; Gedanken A; Lubart R
Photomed Laser Surg; 2013 Nov; 31(11):526-30. PubMed ID: 23448383
[TBL] [Abstract][Full Text] [Related]
28. In vitro and in vivo study on antiprotozoal activity of calcium oxide (CaO) and magnesium oxide (MgO) nanoparticles on promastigote and amastigote forms of Leishmania major.
Ghaffari AD; Barati M; KarimiPourSaryazdi A; Ghaffarifar F; Pirestani M; Ebrahimi M
Acta Trop; 2023 Feb; 238():106788. PubMed ID: 36493855
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of photodynamic therapy using TiO
Sepúlveda AAL; Arenas Velásquez AM; Patiño Linares IA; de Almeida L; Fontana CR; Garcia C; Graminha MAS
Photodiagnosis Photodyn Ther; 2020 Jun; 30():101676. PubMed ID: 32001331
[TBL] [Abstract][Full Text] [Related]
30. 7-Chloro-4-quinolinyl hydrazones: a promising and potent class of antileishmanial compounds.
Coimbra ES; Antinarelli LM; da Silva AD; Bispo ML; Kaiser CR; de Souza MV
Chem Biol Drug Des; 2013 May; 81(5):658-65. PubMed ID: 23350797
[TBL] [Abstract][Full Text] [Related]
31. Mechanism of photogenerated reactive oxygen species and correlation with the antibacterial properties of engineered metal-oxide nanoparticles.
Li Y; Zhang W; Niu J; Chen Y
ACS Nano; 2012 Jun; 6(6):5164-73. PubMed ID: 22587225
[TBL] [Abstract][Full Text] [Related]
32. Effect of ZnO and TiO₂ nanoparticles preilluminated with UVA and UVB light on Escherichia coli and Bacillus subtilis.
Kim SW; An YJ
Appl Microbiol Biotechnol; 2012 Jul; 95(1):243-53. PubMed ID: 22615055
[TBL] [Abstract][Full Text] [Related]
33. Aziridine-2,3-dicarboxylates, peptidomimetic cysteine protease inhibitors with antileishmanial activity.
Ponte-Sucre A; Vicik R; Schultheis M; Schirmeister T; Moll H
Antimicrob Agents Chemother; 2006 Jul; 50(7):2439-47. PubMed ID: 16801424
[TBL] [Abstract][Full Text] [Related]
34. Responses of RAW264.7 macrophages to water-dispersible gold and silver nanoparticles stabilized by metal-carbon σ-bonds.
Hashimoto M; Toshima H; Yonezawa T; Kawai K; Narushima T; Kaga M; Endo K
J Biomed Mater Res A; 2014 Jun; 102(6):1838-49. PubMed ID: 23784947
[TBL] [Abstract][Full Text] [Related]
35. Antileishmanial activity of ruthenium(II)tetraammine nitrosyl complexes.
Pereira JC; Carregaro V; Costa DL; da Silva JS; Cunha FQ; Franco DW
Eur J Med Chem; 2010 Sep; 45(9):4180-7. PubMed ID: 20598778
[TBL] [Abstract][Full Text] [Related]
36. UV and dark-triggered repetitive release and encapsulation of benzophenone-3 from biocompatible ZnO nanoparticles potential for skin protection.
Huang X; Wang X; Wang S; Yang J; Zhong L; Pan J
Nanoscale; 2013 Jun; 5(12):5596-601. PubMed ID: 23680782
[TBL] [Abstract][Full Text] [Related]
37. Uptake and antileishmanial activity of meglumine antimoniate-containing liposomes in Leishmania (Leishmania) major-infected macrophages.
Borborema SE; Schwendener RA; Osso JA; de Andrade HF; do Nascimento N
Int J Antimicrob Agents; 2011 Oct; 38(4):341-7. PubMed ID: 21783345
[TBL] [Abstract][Full Text] [Related]
38. Antileishmanial activity of Urtica dioica extract against zoonotic cutaneous leishmaniasis.
Badirzadeh A; Heidari-Kharaji M; Fallah-Omrani V; Dabiri H; Araghi A; Salimi Chirani A
PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007843. PubMed ID: 31929528
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of biogenic selenium nanoparticles against Leishmania major: in vitro and in vivo studies.
Beheshti N; Soflaei S; Shakibaie M; Yazdi MH; Ghaffarifar F; Dalimi A; Shahverdi AR
J Trace Elem Med Biol; 2013 Jul; 27(3):203-7. PubMed ID: 23219368
[TBL] [Abstract][Full Text] [Related]
40. Effects of zinc oxide and titanium dioxide nanoparticles on green algae under visible, UVA, and UVB irradiations: no evidence of enhanced algal toxicity under UV pre-irradiation.
Lee WM; An YJ
Chemosphere; 2013 Apr; 91(4):536-44. PubMed ID: 23357865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
